ID   SNU-16-DOX
AC   CVCL_L043
DR   Wikidata; Q54955124
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; 1681; CD44 + HGNC; 10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Derived from metastatic site: Ascites.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 20-05-21; Version: 16
//
RX   PubMed=19956504; DOI=10.4143/crt.2005.37.1.1;
RA   Ku J.-L., Park J.-G.;
RT   "Biology of SNU cell lines.";
RL   Cancer Res. Treat. 37:1-19(2005).
//